Literature DB >> 28536996

Models for Studying Myelination, Demyelination and Remyelination.

I Osorio-Querejeta1,2, M Sáenz-Cuesta1,2, M Muñoz-Culla1,2, D Otaegui3,4.   

Abstract

One of the most widely studied demyelinating diseases is multiple sclerosis, which is characterised by the appearance of demyelinating plaques, followed by myelin regeneration. Nevertheless, with disease progression, remyelination tends to fail, increasing the characteristic neurodegeneration of the disease. It is essential to understand the mechanisms that operate in the processes of myelination, demyelination and remyelination to develop treatments that promote the production of new myelin, thereby protecting the central nervous system. A huge variety of models have been developed to help improve our understanding of these processes. Nevertheless, no single model allows us to study all the processes involved in remyelination and usually more than one is needed to provide a full picture of related mechanisms. In this review, we summarise the most commonly used models for studying myelination, demyelination and remyelination and we analyse them critically to outline the most suitable ways of using them.

Entities:  

Keywords:  Cell culture; Demyelination; Experimental models; Multiple sclerosis; Neurodegeneration; Remyelination

Mesh:

Year:  2017        PMID: 28536996     DOI: 10.1007/s12017-017-8442-1

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  87 in total

Review 1.  Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis.

Authors:  Lawrence Steinman; Scott S Zamvil
Journal:  Trends Immunol       Date:  2005-09-08       Impact factor: 16.687

Review 2.  Statistical analysis of data from studies on experimental autoimmune encephalomyelitis.

Authors:  Kandace K Fleming; James A Bovaird; Michael C Mosier; Mitchell R Emerson; Steven M LeVine; Janet G Marquis
Journal:  J Neuroimmunol       Date:  2005-09-29       Impact factor: 3.478

3.  Multiple sclerosis: human model for EAE?

Authors:  Reinhard Hohlfeld
Journal:  Eur J Immunol       Date:  2009-08       Impact factor: 5.532

4.  Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.

Authors:  Emily G Baxi; Joseph DeBruin; Dominique M Tosi; Inna V Grishkan; Matthew D Smith; Leslie A Kirby; Hayley J Strasburger; Amanda N Fairchild; Peter A Calabresi; Anne R Gocke
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

5.  A neurotropic virus isolated from Aedes mosquitoes caught in the Semliki forest.

Authors:  K C SMITHBURN; A J HADDOW; A F MAHAFFY
Journal:  Am J Trop Med Hyg       Date:  1946-03       Impact factor: 2.345

6.  A rapid and reproducible assay for modeling myelination by oligodendrocytes using engineered nanofibers.

Authors:  Seonok Lee; S Y Christin Chong; Samuel J Tuck; Joseph M Corey; Jonah R Chan
Journal:  Nat Protoc       Date:  2013-04       Impact factor: 13.491

7.  Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant.

Authors:  J C Lorentzen; S Issazadeh; M Storch; M I Mustafa; H Lassman; C Linington; L Klareskog; T Olsson
Journal:  J Neuroimmunol       Date:  1995-12-31       Impact factor: 3.478

8.  Ethidium bromide-induced demyelination in the sciatic nerve of diabetic rats.

Authors:  Eduardo Fernandes Bondan; Paulo Ruggiero Custódio; Maria Anete Lallo; Henri Donnarumma Levy Bentubo; Dominguita Luhers Graça
Journal:  Arq Neuropsiquiatr       Date:  2009-12       Impact factor: 1.420

9.  Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system.

Authors:  Trent A Watkins; Ben Emery; Sara Mulinyawe; Ben A Barres
Journal:  Neuron       Date:  2008-11-26       Impact factor: 17.173

Review 10.  Viruses and multiple sclerosis.

Authors:  Jussi Oskari Virtanen; Steve Jacobson
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-08       Impact factor: 4.388

View more
  6 in total

1.  Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes.

Authors:  Valéria de Almeida; Gabriela Seabra; Guilherme Reis-de-Oliveira; Giuliana S Zuccoli; Priscila Rumin; Mariana Fioramonte; Bradley J Smith; Antonio W Zuardi; Jaime E C Hallak; Alline C Campos; José A Crippa; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-05-27       Impact factor: 5.760

2.  Neuroprotective Effects of Melatonin during Demyelination and Remyelination Stages in a Mouse Model of Multiple Sclerosis.

Authors:  Hanin Abdulbaset Abo Taleb; Badrah Saeed Alghamdi
Journal:  J Mol Neurosci       Date:  2019-11-11       Impact factor: 3.444

3.  Atmospheric particulate matter aggravates cns demyelination through involvement of TLR-4/NF-kB signaling and microglial activation.

Authors:  Bing Han; Xing Li; Ruo-Song Ai; Si-Ying Deng; Ze-Qing Ye; Xin Deng; Wen Ma; Shun Xiao; Jing-Zhi Wang; Li-Mei Wang; Chong Xie; Yan Zhang; Yan Xu; Yuan Zhang
Journal:  Elife       Date:  2022-02-24       Impact factor: 8.140

4.  Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.

Authors:  Marije J D Huitema; Eva M M Strijbis; Antonio Luchicchi; John G J M Bol; Jason R Plemel; Jeroen J G Geurts; Geert J Schenk
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

Review 5.  Experimental models of demyelination and remyelination.

Authors:  L Torre-Fuentes; L Moreno-Jiménez; V Pytel; J A Matías-Guiu; U Gómez-Pinedo; J Matías-Guiu
Journal:  Neurologia (Engl Ed)       Date:  2017-08-31

Review 6.  Benefits of hesperidin in central nervous system disorders: a review.

Authors:  Jeongtae Kim; Myung-Bok Wie; Meejung Ahn; Akane Tanaka; Hiroshi Matsuda; Taekyun Shin
Journal:  Anat Cell Biol       Date:  2019-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.